MedTrace Logo

Misoprostol for Spinal Stenosis

NCT04611464 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 23

Last updated 2020-11-02

No results posted yet for this study

Summary

This single-group cross-sectional cohort study will enroll approximately 25 patients at the North Texas VA Health Care System (VANTHCS) who have previously received off-label prescriptions of misoprostol for lumbar spinal stenosis for any duration and who are willing to provide verbal and informed consent. Patients will answer a questionnaire regarding pain and functional improvement especially in reference to misoprostol treatment. Patients will also be selected to have their walking tolerance (claudication distance) measured in an outpatient clinic setting to determine the severity of their lumbar spinal stenosis symptoms after having received misoprostol.

Conditions

  • Lumbar Spinal Stenosis
  • Low Back Pain

Interventions

DRUG

Misoprostol

Misoprostol is a PGE1 analog

Sponsors & Collaborators

  • Dallas VA Medical Center

    lead FED

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-07-11
Primary Completion
2020-06-01
Completion
2020-06-01
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04611464 on ClinicalTrials.gov